Reported Earnings • Oct 27
Third quarter 2022 earnings released: EPS: US$0.001 (vs US$0 in 3Q 2021) Third quarter 2022 results: EPS: US$0.001 (up from US$0 in 3Q 2021). Net income: US$188.0k (up US$248.0k from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 102% per year but the company’s share price has fallen by 46% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 24
Second quarter 2022 earnings released: US$0.001 loss per share (vs US$0.002 profit in 2Q 2021) Second quarter 2022 results: US$0.001 loss per share (down from US$0.002 profit in 2Q 2021). Net loss: US$221.0k (down 146% from profit in 2Q 2021). Reported Earnings • May 14
Full year 2021 earnings released: EPS: US$0.03 (vs US$0.007 loss in FY 2020) Full year 2021 results: EPS: US$0.03 (up from US$0.007 loss in FY 2020). Revenue: US$10.6m (up 81% from FY 2020). Net income: US$8.26m (up US$10.4m from FY 2020). Profit margin: 78% (up from net loss in FY 2020). Buying Opportunity • May 11
Now 75% undervalued after recent price drop Over the last 90 days, the stock is down 87%. The fair value is estimated to be €0.004, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 46% over the last 3 years. Meanwhile, the company has become profitable. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Director Jules Mermoud was the last independent director to join the board, commencing their role in 2012. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Buying Opportunity • Feb 23
Now 53% undervalued Over the last 90 days, the stock is up 7.1%. The fair value is estimated to be US$0.016, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 46% per annum over the last 3 years. The company has become profitable over the last year. Buying Opportunity • Jan 25
Now 65% undervalued after recent price drop Over the last 90 days, the stock is down 93%. The fair value is estimated to be US$0.0014, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 46% per annum over the last 3 years. The company has become profitable over the last year. Reported Earnings • Nov 30
Third quarter 2021 earnings: EPS in line with analyst expectations despite revenue beat Third quarter 2021 results: EPS: US$0.11 (up from US$0.001 loss in 3Q 2020). Revenue: US$3.67m (up 187% from 3Q 2020). Net income: US$1.39m (up US$1.77m from 3Q 2020). Profit margin: 38% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Revenue exceeded analyst estimates by 5.2%. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 27
Second quarter 2021 earnings released The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: US$2.15m (up 126% from 2Q 2020). Net income: US$483.0k (up US$1.68m from 2Q 2020). Profit margin: 22% (up from net loss in 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has fallen by 21% per year, which means it is performing significantly worse than earnings. Reported Earnings • May 29
First quarter 2021 earnings released The company reported a decent first quarter result with improved earnings and profit margins, although revenues were weaker. First quarter 2021 results: Revenue: US$1.76m (down 22% from 1Q 2020). Net income: US$263.0k (up US$969.0k from 1Q 2020). Profit margin: 15% (up from net loss in 1Q 2020). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 16% per year, which means it is significantly lagging earnings. Executive Departure • May 25
Director has left the company On the 18th of May, John Booth's tenure as Director ended after 4.0 years in the role. We don't have any record of a personal shareholding under John's name. A total of 2 executives have left over the last 12 months. Reported Earnings • Apr 02
Full year 2020 earnings released: US$0.01 loss per share (vs US$0.035 loss in FY 2019) The company reported a decent full year result with reduced losses and improved control over expenses, although revenues were weaker. Full year 2020 results: Revenue: US$4.81m (down 59% from FY 2019). Net loss: US$2.11m (loss narrowed 81% from FY 2019). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings. Reported Earnings • Nov 19
Third quarter 2020 earnings released: US$0.007 loss per share The company reported a soft third quarter result with weaker revenues and control over expenses, though losses reduced. Third quarter 2020 results: Revenue: US$946.0k (down 63% from 3Q 2019). Net loss: US$374.0k (loss narrowed 25% from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has fallen by 27% per year, which means it is performing significantly worse than earnings.